Avita Medical Inc Expected To Post A Loss Of 29 Cents A Share: Earnings Preview

AVITA Medical

05/08/2026 24:02

AVITA Medical Inc RCEL.OQ RCEL.O is expected to  show a rise in quarterly revenue when it reports  results on August 6 for the period ending June 30 2026
The Valencia California California-based  company is expected to report a 9.5% increase in revenue to $20.167 million from $18.42 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
​LSEG's mean analyst estimate for AVITA Medical Inc is for a loss of 29 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for AVITA Medical Inc is $6.00, about 29.6% above its last closing price of $4.63
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.31
-0.28
-0.35
Missed
-25
Dec. 31 2026
-0.34
-0.34
-0.38
Missed
-13.1
Sep. 30 2025
-0.32
-0.28
-0.46
Missed
-62​
Jun. 30 2025
-0.25
-0.25
-0.38
Missed
-53.2
​​Mar. 31 2025
-0.38
-0.38
-0.53
Missed
-37.7
Dec. 31 2024
-0.49
-0.43
-0.44
Missed
-1.6​
Sep. 30 2024
-0.44
-0.44
-0.62
Missed
-42.1
Jun. 30 2024
-0.52
-0.52
-0.60
Missed
-15.8
This summary was machine generated August 4 at 23:02 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)